Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ
Market Cap
$95.83M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
504 of 951
Rank in Industry
271 of 544
Largest Insider Buys in Sector
ABOS Stock Price History Chart
ABOS Stock Performance
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Insider Activity of Acumen Pharmaceuticals, Inc.
Over the last 12 months, insiders at Acumen Pharmaceuticals, Inc. have bought $0 and sold $288,695 worth of Acumen Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Acumen Pharmaceuticals, Inc. have bought $49.68M and sold $280,514 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,161,290 shares for transaction amount of $40M was made by RA CAPITAL MANAGEMENT, L.P. () on 2023‑07‑21.
List of Insider Buy and Sell Transactions, Acumen Pharmaceuticals, Inc.
| 2025-01-03 | Sale | Chief Executive Officer | 47,778 0.0774% | $1.84 | $87,873 | -10.00% | ||
| 2025-01-03 | Sale | CFO & Chief Business Officer | 13,235 0.0215% | $1.84 | $24,367 | -10.00% | ||
| 2025-01-03 | Sale | Chief Medical Officer | 10,859 0.0177% | $1.85 | $20,047 | -10.00% | ||
| 2025-01-03 | Sale | Chief Legal Officer & Corp Sec | 11,122 0.0181% | $1.84 | $20,506 | -10.00% | ||
| 2025-01-03 | Sale | Chief Operating Officer | 7,636 0.0125% | $1.86 | $14,225 | -10.00% | ||
| 2024-01-19 | Sale | President and CEO | 15,200 0.0253% | $3.47 | $52,753 | -18.40% | ||
| 2024-01-19 | Sale | Chief Legal Officer & Corp Sec | 8,933 0.0149% | $3.48 | $31,048 | -18.40% | ||
| 2024-01-18 | Sale | CFO & Chief Business Officer | 4,242 0.0075% | $3.71 | $15,717 | -19.29% | ||
| 2024-01-18 | Sale | Chief Medical Officer | 3,124 0.0055% | $3.71 | $11,604 | -19.29% | ||
| 2024-01-18 | Sale | Chief Operating Officer | 2,833 0.005% | $3.73 | $10,555 | -19.29% | ||
| 2023-08-17 | Sale | director | 41,949 0.0739% | $6.49 | $272,334 | -46.80% | ||
| 2023-07-21 | 5.16M 13.1759% | $7.75 | $40M | -51.62% | ||||
| 2021-07-06 | 1.88M 3.8811% | $16.00 | $30M | -67.95% | ||||
| 2021-07-06 | 10 percent owner | 1.06M 2.1993% | $16.00 | $17M | -67.95% | |||
| 2021-07-06 | 10 percent owner | 450,000 0.8663% | $14.88 | $6.7M | -67.95% | |||
| 2021-07-06 | 10 percent owner | 312,500 0.6468% | $16.00 | $5M | -67.95% | |||
| 2021-07-06 | director | 35,000 0.0724% | $16.00 | $560,000 | -67.95% | |||
| 2021-07-06 | director | 6,250 0.0129% | $16.00 | $100,000 | -67.95% |
Insider Historical Profitability
<0.0001%
| OConnell Daniel Joseph | Chief Executive Officer | 454707 0.7568% | $1.60 | 0 | 2 | |
| Zuga Matt | CFO & Chief Business Officer | 198210 0.3299% | $1.60 | 0 | 2 | |
| Siemers Eric | Chief Medical Officer | 106717 0.1776% | $1.60 | 0 | 2 | |
| Meisner Derek M | Chief Legal Officer & Corp Sec | 97745 0.1627% | $1.60 | 0 | 2 | |
| Barton Russell | Chief Operating Officer | 89231 0.1485% | $1.60 | 0 | 2 | |
| RA CAPITAL MANAGEMENT, L.P. | 13043179 21.7098% | $1.60 | 2 | 0 | <0.0001% | |
| Hardie Robert D. | 10 percent owner | 3951156 6.5765% | $1.60 | 1 | 0 | <0.0001% |
| Sands Capital Ventures Discovery Fund III, L.P. | 10 percent owner | 3417075 5.6876% | $1.60 | 1 | 0 | <0.0001% |
| Manning Paul B | 10 percent owner | 3352693 5.5804% | $1.60 | 1 | 0 | <0.0001% |
| Stalfort John A III | director | 172324 0.2868% | $1.60 | 1 | 0 | <0.0001% |
| Fountain Nathan B | director | 6250 0.0104% | $1.60 | 1 | 0 | <0.0001% |
| Ives Jeffrey L. | director | 0 0% | $1.60 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| RA Capital Management, L.P. | $60.47M | 24.85 | 14.93M | 0% | +$0 | 0.06 | |
| Sands Capital Ventures LLC | $13.84M | 5.69 | 3.42M | 0% | +$0 | 3.34 | |
| Franklin Templeton Investments | $13.75M | 5.65 | 3.4M | +1.09% | +$148,266.45 | <0.01 | |
| Millennium Management LLC | $10.65M | 4.38 | 2.63M | +75.86% | +$4.59M | 0.01 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $9.32M | 3.83 | 2.3M | 0% | +$0 | 0.24 | |
| Fidelity Investments | $8.46M | 3.48 | 2.09M | New | +$8.46M | <0.01 | |
| Laurion Capital Management LP | $7.67M | 3.15 | 1.9M | 0% | +$0 | 0.05 | |
| The Vanguard Group | $6.74M | 2.77 | 1.67M | -9.49% | -$706,700.71 | <0.0001 | |
| T. Rowe Price | $4.45M | 1.83 | 1.1M | New | +$4.45M | <0.01 | |
| Alyeska Investment Group L P | $3.81M | 1.56 | 939,603 | +28.15% | +$835,919.97 | 0.02 | |
| Jane Street Capital | $2.43M | 1 | 600,255 | -0.72% | -$17,678.25 | <0.01 | |
| Parkman Healthcare Partners Llc | $2.34M | 0.96 | 576,657 | -4.45% | -$108,702.01 | 0.29 | |
| Hudson Bay Capital Management LP | $2.27M | 0.93 | 560,000 | -0.78% | -$17,820.00 | 0.02 | |
| Schonfeld Group | $1.86M | 0.76 | 458,484 | -18.35% | -$417,384.63 | 0.01 | |
| Goldman Sachs | $1.29M | 0.53 | 317,904 | +177.08% | +$822,846.47 | <0.0001 | |
| Geode Capital Management | $1.16M | 0.48 | 285,139 | +7.76% | +$83,190.82 | <0.0001 | |
| Ikarian Capital LLC | $1.08M | 0.44 | 266,435 | -15.49% | -$197,761.73 | 0.15 | |
| Susquehanna International Group | $1.08M | 0.44 | 265,843 | -46.81% | -$947,501.42 | <0.01 | |
| Tang Capital Management, LLC | $999,925.00 | 0.41 | 246,895 | 0% | +$0 | <0.01 | |
| Two Sigma Advisers LP | $878,850.00 | 0.36 | 217,000 | +67.31% | +$353,565.00 | <0.01 | |
| BlackRock | $768,273.00 | 0.32 | 189,697 | -23.54% | -$236,511.95 | <0.0001 | |
| Man Group Plc | $759,719.00 | 0.31 | 187,585 | +29.7% | +$173,967.69 | <0.01 | |
| Two Sigma | $720,499.00 | 0.3 | 177,901 | -27.21% | -$269,385.73 | <0.01 | |
| Qube Research & Technologies | $678,731.00 | 0.28 | 167,588 | +89.1% | +$319,795.91 | <0.01 | |
| Td Asset Management Inc | $602,640.00 | 0.25 | 148,800 | New | +$602,640.00 | <0.01 | |
| Bridgeway Capital Management | $601,020.00 | 0.25 | 148,400 | New | +$601,020.00 | 0.01 | |
| Citigroup | $548,346.00 | 0.23 | 135,394 | -8.4% | -$50,288.88 | <0.0001 | |
| Squarepoint Ops LLC | $458,590.00 | 0.19 | 113,232 | +114.34% | +$244,632.36 | <0.01 | |
| Wellington Management Company | $454,645.00 | 0.19 | 112,258 | New | +$454,645.00 | <0.0001 | |
| Hrt Financial Llc | $425,000.00 | 0.18 | 105,117 | New | +$425,000.00 | <0.01 | |
| New York Life Investment Management Llc | $385,110.00 | 0.16 | 95,089 | New | +$385,110.00 | <0.01 | |
| Marshall Wace | $363,314.00 | 0.15 | 89,707 | New | +$363,314.00 | <0.0001 | |
| Catalyst Financial Partners Llc | $311,256.00 | 0.15 | 89,699 | 0% | +$0 | 0.08 | |
| State Street | $331,201.00 | 0.14 | 81,778 | -3.88% | -$13,365.00 | <0.0001 | |
| Bank of America | $326,495.00 | 0.13 | 80,616 | -22.76% | -$96,199.71 | <0.0001 | |
| JPMorgan Chase | $291,155.00 | 0.12 | 71,890 | +111.78% | +$153,677.51 | <0.0001 | |
| Balyasny Asset Management Llc | $258,993.00 | 0.11 | 63,949 | +210.76% | +$175,652.24 | <0.01 | |
| Susquehanna Fundamental Investments Llc | $253,198.00 | 0.1 | 62,518 | New | +$253,198.00 | 0.01 | |
| Dimensional Fund Advisors | $249,999.00 | 0.1 | 61,728 | +10.64% | +$24,044.91 | <0.0001 | |
| The Manufacturers Life Insurance Company | $243,166.00 | 0.1 | 60,041 | New | +$243,166.00 | <0.0001 | |
| Marathon Trading Investment Management Llc | $243,000.00 | 0.1 | 60,000 | New | +$243,000.00 | 0.05 | |
| Brevan Howard Capital Management Lp | $228,294.00 | 0.09 | 56,369 | New | +$228,294.00 | 0.02 | |
| Northern Trust | $229,931.00 | 0.09 | 56,773 | +0.17% | +$384.75 | <0.0001 | |
| Boothbay Fund Management LLC | $209,417.00 | 0.09 | 51,708 | -37.08% | -$123,419.46 | 0.01 | |
| Morgan Stanley | $197,284.00 | 0.08 | 48,712 | +110.64% | +$103,623.51 | <0.0001 | |
| Barclays | $191,000.00 | 0.08 | 47,310 | -0.08% | -$149.38 | <0.0001 | |
| Prelude Capital | $149,850.00 | 0.06 | 37,000 | +27.15% | +$31,995.00 | 0.01 | |
| Y Intercept Hong Kong Ltd | $150,624.00 | 0.06 | 37,191 | +92.22% | +$72,264.37 | 0.01 | |
| American Century Investments | $140,146.00 | 0.06 | 34,604 | +39.94% | +$39,997.74 | <0.0001 | |
| Bank of Montreal | $131,747.00 | 0.05 | 31,900 | New | +$131,747.00 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.